Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BDSI

BioDelivery Sciences (BDSI)

BioDelivery Sciences International Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BDSI
FechaHoraFuenteTítuloSímboloCompañía
10/02/202315:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BDSIBioDelivery Sciences International Inc
24/03/202205:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202216:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202216:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202216:02Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202216:01GlobeNewswire Inc.Collegium Completes the Acquisition of BDSINASDAQ:BDSIBioDelivery Sciences International Inc
21/03/202206:08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:BDSIBioDelivery Sciences International Inc
21/03/202206:02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:BDSIBioDelivery Sciences International Inc
24/02/202211:07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BDSIBioDelivery Sciences International Inc
24/02/202210:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BDSIBioDelivery Sciences International Inc
18/02/202216:20Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:BDSIBioDelivery Sciences International Inc
18/02/202215:54Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:BDSIBioDelivery Sciences International Inc
15/02/202215:57Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:BDSIBioDelivery Sciences International Inc
15/02/202215:55Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BDSIBioDelivery Sciences International Inc
14/02/202206:45Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:BDSIBioDelivery Sciences International Inc
03/11/202115:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BDSIBioDelivery Sciences International Inc
16/08/202107:00GlobeNewswire Inc.AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of DirectorsNASDAQ:BDSIBioDelivery Sciences International Inc
11/03/202105:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BDSIBioDelivery Sciences International Inc
15/07/202015:56Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BDSIBioDelivery Sciences International Inc
01/06/202016:24Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BDSIBioDelivery Sciences International Inc
11/05/202007:30GlobeNewswire Inc.BioDelivery Sciences Appoints Jeff Bailey Interim CEONASDAQ:BDSIBioDelivery Sciences International Inc
07/05/202015:01GlobeNewswire Inc.BioDelivery Sciences Reports Strong Q1 2020 ResultsNASDAQ:BDSIBioDelivery Sciences International Inc
28/04/202007:00GlobeNewswire Inc.BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020NASDAQ:BDSIBioDelivery Sciences International Inc
17/03/202015:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BDSIBioDelivery Sciences International Inc
12/03/202015:01GlobeNewswire Inc.BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 ResultsNASDAQ:BDSIBioDelivery Sciences International Inc
09/03/202007:00GlobeNewswire Inc.BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of DirectorsNASDAQ:BDSIBioDelivery Sciences International Inc
27/02/202016:15GlobeNewswire Inc.BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual Meetin...NASDAQ:BDSIBioDelivery Sciences International Inc
20/02/202007:00GlobeNewswire Inc.BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020NASDAQ:BDSIBioDelivery Sciences International Inc
13/01/202007:30GlobeNewswire Inc.BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Ac...NASDAQ:BDSIBioDelivery Sciences International Inc
06/01/202007:30GlobeNewswire Inc.BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business DevelopmentNASDAQ:BDSIBioDelivery Sciences International Inc
 Showing the most relevant articles for your search:NASDAQ:BDSI